Fit comes before format
An injection or pill is only useful if its safety profile, administration routine, access, and cost make sense for you.
Physician-led GLP-1 care in Iowa
GLP-1 Weight Loss Care: Compare Medication and Program Options
Compare GLP-1 injections and pills, candidacy, side effects, and physician-led virtual Iowa or in-person Ankeny care with current WellForm program pricing.
- Injection and pill options
- Virtual or Ankeny care
- Transparent program pricing
Choose for fit
History, goals, side-effect risk, treatment routine, access, and cost matter more than which medication is most talked about.
Two care settings
Eligible Iowa patients can choose virtual care, while the Ankeny program adds in-clinic services and body-composition follow-up.
Plan for follow-up
Starting is only the first decision. Response, tolerability, nutrition, activity, and affordability are reviewed over time.
The decision that matters
You are choosing a care plan—not just a popular medication
A GLP-1 can be a powerful treatment tool, but the practical question is whether a specific medicine, routine, cost, and follow-up plan fit your health and your life.
GLP-1 is a hormone signal involved in appetite, fullness, glucose regulation, and digestion. Medicines that activate the GLP-1 receptor can reduce hunger, help meals feel more satisfying, and slow stomach emptying. Tirzepatide also activates the GIP receptor. These effects can make a medically supported weight-loss plan more workable; they do not make every medication interchangeable or remove the need for nutrition, activity, and follow-up.
A useful first visit therefore looks beyond “Which one causes the most weight loss?” Dr. Oben reviews your medical history, previous treatment, daily preferences, side-effect concerns, pharmacy access, and the amount you can realistically sustain. The best starting path is the one that is clinically appropriate and still workable after the first month.
The plan can change
Response, tolerability, supply, and preference may lead the plan to continue, slow down, switch, or stop.
Make the category usable
Start with active ingredient and treatment routine
The broad GLP-1 conversation currently includes three distinct paths. The right comparison is molecule, route, evidence, safety, and access—not brand recognition alone.
- 01
Semaglutide
A GLP-1 receptor agonist available in branded weight-management products, including Wegovy pen and tablet forms, as well as separately governed compounded programs.
- 02
Tirzepatide
A once-weekly injectable medicine that activates GIP and GLP-1 receptors. Zepbound is the weight-management brand; compounded tirzepatide is a separate product category.
- 03
Orforglipron
The active ingredient in FoundAyo, a once-daily oral GLP-1 receptor agonist that can be taken with or without food.
FDA-approved brands have product-specific prescribing information. Compounded semaglutide and tirzepatide are not FDA-approved and are not generic versions of the brands.
Choose how you want to be cared for
WellForm Virtual / Online versus In-Person Ankeny GLP-1 care
Both pathways are physician-led. The difference is where follow-up happens, whether medication is included in the listed price, and whether you want the Ankeny clinic-service bundle.
Virtual / online across Iowa
GLP-1 care from home
For eligible Iowa patients who want remote physician management, nutrition guidance, and coaching without regular visits to the Ankeny clinic.
Compounded
$220 / $320
First month of virtual compounded semaglutide / tirzepatide, including medication.
Branded
$150/month
WellForm virtual medical management for Wegovy, Zepbound, or FoundAyo.
Branded medication cost is separate and is paid through the applicable pharmacy or manufacturer pathway; WellForm does not dispense or sell it.
What care includes
- Physician evaluation and medication management
- Regular response and side-effect follow-up
- Nutrition guidance
- Coaching and plan adjustment
Virtual care does not include the in-clinic InBody, UltraSlim, Ballancer Pro, or Power Plate services.
Book a virtual consultationIn person in Ankeny
GLP-1 care with clinic support
For patients who want face-to-face physician follow-up, serial body-composition context, and the current in-clinic support bundle.
Compounded
$325 / $475
Monthly compounded semaglutide / tirzepatide starts at these prices, including medication.
Branded
$300/month
WellForm in-person medical management for Wegovy, Zepbound, or FoundAyo.
Branded medication cost is separate and is paid through the applicable pharmacy or manufacturer pathway; WellForm does not dispense or sell it.
What care includes
- Monthly physician follow-up
- Monthly InBody body-composition scan
- UltraSlim red-light session
- Ballancer Pro lymphatic-care session
- Power Plate session
- Nutrition guidance and optional Quest labs
Included clinic services are provided at no additional charge. Selected higher-dose plans may also include EMSCULPT NEO.
Book an Ankeny consultationA consultation does not guarantee medication. Exact eligibility, product, pharmacy, dose band, ongoing compounded-program price, and brand-medication cost are confirmed before enrollment. Published prices and manufacturer access programs can change.
Route to the decision you are making
Compare the molecule or brand—not a pile of names
This page owns the class-level decision. Use the focused guide that matches the exact medication question you want to answer next.
Semaglutide
Understand expected treatment experience, compounded and brand paths, side effects, and comparison with tirzepatide.
Continue
Wegovy
Review Wegovy pen and tablet care, access, administration, and the difference from compounded semaglutide.
Continue
Tirzepatide
Learn how dual GIP and GLP-1 activity differs from semaglutide and what monitored treatment involves.
Continue
Zepbound
Consider the branded tirzepatide path, realistic expectations, LillyDirect access, and WellForm follow-up.
Continue
FoundAyo
Decide whether a once-daily oral GLP-1 routine may fit better than an injection.
Continue
What treatment actually involves
The medication decision continues after the prescription
GLP-1 care is a sequence of clinical decisions: establish fit, learn how your body responds, find a tolerable pace, and decide whether the plan remains worthwhile.
- 1
Build the clinical picture
Review goals, health history, current medicines, previous treatment, pregnancy plans, symptoms, and optional labs when they add useful context.
- 2
Confirm the exact path
Identify the medicine, dosage form, pharmacy, administration routine, complete cost, and what follow-up is included before starting.
- 3
Learn the early response
During gradual product-specific escalation, track appetite, meal tolerance, hydration, bowel symptoms, energy, and daily function—not only the scale.
- 4
Reassess the whole plan
Review weight and body-composition context, side effects, nutrition, strength goals, affordability, and whether to continue, adjust, switch, or stop.
If progress is limited, follow-up checks administration, escalation, tolerability, nutrition, activity, sleep, other medications, medical contributors, and access before assuming the answer is simply a higher dose.
Candidacy is product-specific
A GLP-1 conversation can be reasonable without guaranteeing a prescription
Dr. Oben applies the eligibility and safety information for the exact product under consideration, then weighs whether the treatment burden and follow-up needs are realistic for you.
Reasons to consider evaluation
- You meet the labeled weight-management criteria for the FDA-approved product being considered.
- Lifestyle efforts alone have not produced enough durable progress, or hunger makes the plan unusually difficult to sustain.
- You are prepared for ongoing follow-up, nutrition and activity work, and a long-term affordability discussion.
History that needs careful review
- Pregnancy, pregnancy plans, prior serious medication reactions, or a personal or family history of medullary thyroid carcinoma or MEN 2.
- Severe gastroparesis or other significant gastrointestinal disease, pancreatitis, gallbladder, kidney, or diabetic-eye history.
- Insulin, sulfonylureas, another GLP-1 medicine, or oral medicines whose absorption or reliability may be affected.
When response is disappointing
- Confirm the exact product, administration, refill continuity, and dose trajectory.
- Review side effects, meal pattern, hydration, activity, sleep, and other medical contributors.
- Change course when benefit, tolerability, access, or cost no longer justify the plan.
Long-term feasibility
- Discuss maintenance and what could happen after stopping before treatment feels urgent.
- Protect protein intake, strength-focused activity, hydration, and function as appropriate.
- Keep clinical support available for plateaus, procedures, pregnancy, supply changes, or new symptoms.
The visit may reasonably end with a GLP-1 prescription, a different treatment path, more evaluation, or no medication. That is part of responsible selection—not a failed consultation.
Practical adverse-effect planning
Know what is common, what can be managed, and when to call
Gastrointestinal symptoms are common across current GLP-1-based options, but the exact warning, interaction, and administration profile belongs to the specific product.
Review before starting
- Review the complete medication list, diabetes treatment, pregnancy plans, prior reactions, gastrointestinal history, and upcoming procedures.
- Confirm the active ingredient, dosage form, pharmacy source, storage, and product-specific instructions.
- Plan how you will reach the care team if eating, drinking, bowel function, or daily activity becomes difficult.
Common treatment issues
- Nausea, vomiting, diarrhea, constipation, abdominal discomfort, reflux, and reduced appetite can occur.
- Smaller meals, slower eating, adequate fluids, and clinician-guided adjustments may improve tolerance for some people.
- Do not accelerate escalation on your own; response and tolerability both inform the pace.
Contact the care team
Contact the care team for persistent vomiting, inability to stay hydrated, severe or worsening abdominal pain, marked constipation with distension or inability to pass gas, allergic symptoms, vision changes, or symptoms that interfere with daily function. Tell procedure teams that you use a GLP-1 medicine before anesthesia or deep sedation.
One focused safety conversation is more useful than repeating the same disclaimer throughout the page. The prescribing information and your product-specific counseling remain the controlling sources.
Ready to compare the complete paths?
Start with the setting, support, and cost you can sustain.
A free consultation can clarify whether a GLP-1 evaluation is appropriate, which medication questions matter, and whether WellForm Virtual / Online or In-Person Ankeny care fits you better.
- Physician-led evaluation
- Current prices reviewed before enrollment
- No guaranteed prescription
Current source discipline
Medication facts stay tied to the exact product
Current prescribing information establishes approved uses, administration, contraindications, warnings, and clinical-study context. FDA guidance governs how compounded GLP-1 products are described.
Questions that change the decision
GLP-1 questions before you book
These answers can help you arrive at the consultation with a useful decision—not just a medication request.
A responsible next step
Choose the care path before you chase a medication name.
Meet with Dr. Patrick Oben to compare appropriate GLP-1 options, understand the complete cost, and decide whether virtual or in-person care fits how you want to be supported.
